Skip to main content

News Archive

News Archive - School of Medicine

Debashis Sahoo: From Computers to Cancer Genomes

September 23, 2016

Prof. Sahoo – whose journey into the world of cancer genomics was borne from his background in computer science – has been selected as a participating member of the Cancer Genomes and Networks program at UC San Diego Moores Cancer Center.

At Bat Against Rare Blood Cancers

September 20, 2016

University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials planned for 2017.

Do These Genes Make Me Lonely? Study Finds Loneliness is a Heritable Trait

September 20, 2016

Loneliness is linked to poor physical and mental health, and is an even more accurate predictor of early death than obesity. To better understand who is at risk, researchers at University of California San Diego School of Medicine conducted the first genome-wide association study for loneliness — as a life-long trait, not a temporary state. They discovered that risk for feeling lonely is partially due to genetics, but environment plays a bigger role.

Landmark National Study of Adolescent Brain Now Underway

September 19, 2016

If you’ve lived through your own or your kids’ adolescence, you know it’s an extraordinary time. Yet researchers know comparatively little about the teenage brain. The Adolescent Brain Cognitive Development (ABCD) study – by the National Institutes of Health, with leadership from the University of California San Diego – aims to change that. The largest long-term study of brain development and child health in the United States is now underway.

Molecular Switch Controlling Immune Suppression May Help Turn Up Immunotherapies

September 19, 2016

Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers identified a molecular switch that controls immune suppression, opening the possibility to further improving and refining emerging immunotherapies that boost the body’s own abilities to fight diseases ranging from cancer to Alzheimer’s and Crohn’s disease.

Researchers Say to Conquer Cancer You Need to Stop It Before It Becomes Cancer

September 16, 2016

In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.

UC San Diego Among Top 10 Best Public Universities in Nation, According to U.S. News & World Report

September 12, 2016

The University of California San Diego is ranked the 10th best public university in the nation by the U.S. News & World Report Best Colleges guidebook, released today. For more than a decade, the publication has included UC San Diego in its list of the nation’s top 10 public universities.

Six-Day Clinical Trial Finds Integrative Medicine Program Alters Blood Serum

September 9, 2016

In a novel controlled clinical trial, participants in a six-day Ayurvedic-based well-being program that featured a vegetarian diet, meditation, yoga and massages experienced measurable decreases in a set of blood-based metabolites associated with inflammation, cardiovascular disease risk and cholesterol regulation.

10 Cancer Moonshot Blue Ribbon Panel Recommendations Embraced by NCI

September 7, 2016

When 28 distinguished individuals convened earlier this year to help shape the scientific mission at the National Cancer Institute (NCI) of Vice President Joe Biden’s National Cancer Moonshot Initiative, they were given five months to draft guidelines to accelerate cancer research, prevention and care. On Wednesday, the National Cancer Advisory Board approved the Blue Ribbon Panel’s 10 recommendations.

UC San Diego a Prominent Presence at Startups Demo Day in D. C.

September 7, 2016

One of the hundreds of companies hatched by the University of California San Diego has a prominent presence in a national showcase of high-potential startups in the nation’s capital. Curtana Pharmaceuticals plays a big role in the high-visibility Washington, D.C. celebration as a major presenter.
Category navigation with Social links